Â鶹´«Ã½É«ÇéƬ

The Â鶹´«Ã½É«ÇéƬ and Â鶹´«Ã½É«ÇéƬ Biology has teamed up with to provide ASBMB members fresh industry partnership opportunities each month. Below you'll find several requests for assistance from companies seeking certain expertise and technologies. Learn more about our partnership with Halo.

BASF: Enhancing single-copy T-DNA plant transformation with Agrobacterium tumefaciens

BASF is looking to develop a protocol that improves the efficiency of Agrobacterium transformations, generating high proportions of transgenic plants with intact, single copy T-DNA insertions through tissue culture regeneration. They are open to solutions that have a technology readiness level of 1 to 5. The deadline to apply is Nov. 30. Read more about the project call . 

Daiichi Sankyo: Gene therapy for normalizing repeat sequences in repeat expansion disorders

Daiichi Sankyo is looking for novel gene therapeutic technologies to selectively normalize or reduce the expression of abnormal repeat expansions. This includes approaches that utilize adeno-associated virus (AAV)-derived nucleic acids, proteins (peptides), and regulatory factors to inhibit transcription or promote the degradation of repeat sequences. Additionally, they are interested in AAV-derived genome editing technologies that have unique features regarding editing efficiency, versatility and safety for normalizing repeat sequences. Up to $100,000 in funding is available for a 12-month project with the potential for follow-on funding. The deadline to apply is Nov. 30. Read more about the project call . 

Daiichi Sankyo: Gene therapy for chromosomal abnormalities

Daiichi Sankyo is looking for innovative research projects that can evaluate the efficacy of gene therapies targeting specific genes in chromosomal abnormalities. Their primary interest is in research focused on Down syndrome (trisomy 21), but other conditions such as trisomy 13, trisomy 18, as well as 5p- and 4p- syndromes are also within the scope. They are also interested in research focused on identifying key target genes involved in these abnormalities. Up to $100,000 in funding is available for a 12-month project with the potential for follow-on funding. The deadline to apply is Nov. 30. Read more about the project call .

Daiichi Sankyo: Exploratory research for novel gene therapy targets

Daiichi Sankyo is looking for innovative research projects that can identify and explore novel targets for gene therapy, particularly in central nervous system and cardiovascular and metabolism related diseases. They are interested in proposals that explore therapeutic effects through gene supplementation, knockdown or a combination of both. The targets should be delivered by adeno-associated virus to the relevant tissues and cell types and should be distinguishable from existing therapies. Up to $100,000 in funding is available for a 12-month project with the potential for follow-on funding. The deadline to apply is Nov. 30. Read more about the project call.

Private company: Extending and predicting the shelf life of fresh meat-based products

This private company is seeking innovative technologies to preserve the freshness of refrigerated consumable products, ensuring they meet safety and quality standards. These products are based on animal protein and may contain various inclusions such as fruits, vegetables, grains, meat pieces, eggs and other essential ingredients (like vitamins and minerals) to provide complete and balanced nutrition and maintain product quality throughout their shelf life. They are particularly interested in solutions that extend shelf life without compromising taste, texture and nutritional value. Alternatively, they are also interested in technologies/models that can provide high-accuracy prediction of a product's shelf-life for such products. The deadline to apply is Nov. 30. Read more about the project call  

Private company: Sustainable cross-linkers for enhanced performance

This private company is looking for low-hazard crosslinking systems that balance performance with biodegradability. Specifically, they are interested in cross-linkers and building blocks that, when combined with synthetic or natural building blocks, enable high crosslinking density while allowing the material to degrade naturally. Up to €150,000 in funding is available depending on the work plan. The deadline to apply is Nov. 30. Read more about the project call

Private company: Continuous production processes for encapsulation systems

This private company is seeking experts in process optimization and reactor design to assist in the transition to continuous or semi-continuous encapsulation production. The goal is to improve productivity and energy efficiency while making sure flow dynamics, temperature and pressure conditions are kept optimum throughout operation. Up to €150,000 in funding is available depending on the work plan. The deadline to apply is Nov. 30. Read more about the project call .